The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matesic, D.
Right arrow Articles by Heeger, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matesic, D.
Right arrow Articles by Heeger, P. S.
The Journal of Immunology, 1998, 161: 5236-5244.
Copyright © 1998 by The American Association of Immunologists

Type 2 Immune Deviation Has Differential Effects on Alloreactive CD4+ and CD8+ T Cells1

Damir Matesic*, Anna Valujskikh*, Eric Pearlman{dagger}, Alan W. Higgins{dagger}, Anita C. Gilliam{ddagger} and Peter S. Heeger2,*,{dagger}

* Department of Medicine, Cleveland Veteran’s Affairs Medical Center, Cleveland, OH 44106; {dagger} Case Western Reserve University, Cleveland, OH 44106; {ddagger} Department of Dermatology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, OH 44106; and § Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106

Allograft rejection has been associated with detection of the type 1 lymphokines, IFN-{gamma} and IL-2. The role of type 2 cytokines (IL-4 and IL-5) remains controversial, as is whether alloreactive CD4+ and CD8+ T cells behave similarly when exposed to type 2 cytokine-enhancing manipulations. We studied the characteristics of alloreactive CD4+ and CD8+ T cells before and after type 2 immune deviation induced by IL-4 plus anti-IFN-{gamma} Ab. Alloreactive T cells from naive mice were low in frequency, produced only IL-2, and were predominantly CD4+, while alloreactive T cells from allograft-primed mice were high in frequency, produced IFN-{gamma}, IL-2, and IL-4, and were predominantly CD8+. Type 2 immune deviation of allospecific CD4+ T cells resulted in IL-4 and IL-5 production without IFN-{gamma}, consistent with unipolar type 2 immunity. These T cells mediated delayed-type hypersensitivity, but not cytotoxicity. Under identical type 2 cytokine-inducing conditions, allospecific CD8+ T cells were primed to become IL-4, IL-5, and IFN-{gamma} producers, and exhibited cytotoxicity, but not classic delayed-type hypersensitivity. Adoptive transfer of either cell population into SCID recipients of allogeneic skin resulted in graft rejection, with stable allospecific type 2 cytokine production in vivo. Adoptive transfer of the IL-4/IL-5-producing CD4+ T cells, but not the CD8+ T cells, induced a distinct histopathology characterized by marked eosinophilic infiltration of the skin. We conclude that type 2 immune deviation has differential effects on CD4+ and CD8+ T cells and results in emergence of alternate effector mechanisms capable of destroying allografts.




This article has been cited by other articles:


Home page
J. Immunol.Home page
V. Pavlov, H. Raedler, S. Yuan, S. Leisman, W.-h. Kwan, P. N. Lalli, M. E. Medof, and P. S. Heeger
Donor Deficiency of Decay-Accelerating Factor Accelerates Murine T Cell-Mediated Cardiac Allograft Rejection
J. Immunol., October 1, 2008; 181(7): 4580 - 4589.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R P Anderson, D A van Heel, J A Tye-Din, M Barnardo, M Salio, D P Jewell, and A V S Hill
T cells in peripheral blood after gluten challenge in coeliac disease
Gut, September 1, 2005; 54(9): 1217 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Amano, A. Bickerstaff, C. G. Orosz, A. C. Novick, H. Toma, and R. L. Fairchild
Absence of Recipient CCR5 Promotes Early and Increased Allospecific Antibody Responses to Cardiac Allografts
J. Immunol., May 15, 2005; 174(10): 6499 - 6508.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Yamada, A. D. Salama, M. Sho, N. Najafian, T. Ito, J. P. Forman, R. Kewalramani, S. Sandner, H. Harada, M. R. Clarkson, et al.
CD70 Signaling Is Critical for CD28-Independent CD8+ T Cell-Mediated Alloimmune Responses In Vivo
J. Immunol., February 1, 2005; 174(3): 1357 - 1364.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. L. Hargrave, C. Hay, J. Mellon, E. Mayhew, and J. Y. Niederkorn
Fate of MHC-Matched Corneal Allografts in Th1-Deficient Hosts
Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1188 - 1193.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Chen, Y. Demir, A. Valujskikh, and P. S. Heeger
Antigen Location Contributes to the Pathological Features of a Transplanted Heart Graft
Am. J. Pathol., April 1, 2004; 164(4): 1407 - 1415.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. He, S. Schenk, Q. Zhang, A. Valujskikh, J. Bayer, R. L. Fairchild, and P. S. Heeger
Effects of T Cell Frequency and Graft Size on Transplant Outcome in Mice
J. Immunol., January 1, 2004; 172(1): 240 - 247.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Pantenburg, F. Heinzel, L. Das, P. S. Heeger, and A. Valujskikh
T Cells Primed by Leishmania major Infection Cross-React with Alloantigens and Alter the Course of Allograft Rejection
J. Immunol., October 1, 2002; 169(7): 3686 - 3693.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sho, A. Yamada, N. Najafian, A. D. Salama, H. Harada, S. E. Sandner, A. Sanchez-Fueyo, X. X. Zheng, T. B. Strom, and M. H. Sayegh
Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size
J. Immunol., October 1, 2002; 169(7): 3744 - 3751.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Coudert, C. Coureau, and J.-C. Guery
Preventing NK Cell Activation by Donor Dendritic Cells Enhances Allospecific CD4 T Cell Priming and Promotes Th Type 2 Responses to Transplantation Antigens
J. Immunol., September 15, 2002; 169(6): 2979 - 2987.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Boisgerault, Y. Liu, N. Anosova, E. Ehrlich, M. R. Dana, and G. Benichou
Role of CD4+ and CD8+ T Cells in Allorecognition: Lessons from Corneal Transplantation
J. Immunol., August 15, 2001; 167(4): 1891 - 1899.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Yamada, K. Kishimoto, V. M. Dong, M. Sho, A. D. Salama, N. G. Anosova, G. Benichou, D. A. Mandelbrot, A. H. Sharpe, L. A. Turka, et al.
CD28-independent Costimulation of T Cells in Alloimmune Responses
J. Immunol., July 1, 2001; 167(1): 140 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. S. Heeger, A. Valujskikh, and P. V. Lehmann23
Comprehensive Assessment of Determinant Specificity, Frequency, and Cytokine Signature of the Primed CD8 Cell Repertoire Induced by a Minor Transplantation Antigen
J. Immunol., August 1, 2000; 165(3): 1278 - 1284.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Le Moine, M. Surquin, F. X. Demoor, J. C. Noel, M.-A. Nahori, M. Pretolani, V. Flamand, M. Y. Braun, M. Goldman, and D. Abramowicz
IL-5 Mediates Eosinophilic Rejection of MHC Class II-Disparate Skin Allografts in Mice
J. Immunol., October 1, 1999; 163(7): 3778 - 3784.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. S. Heeger, N. S. Greenspan, S. Kuhlenschmidt, C. Dejelo, D. E. Hricik, J. A. Schulak, and M. Tary-Lehmann
Pretransplant Frequency of Donor-Specific, IFN-{gamma}-Producing Lymphocytes Is a Manifestation of Immunologic Memory and Correlates with the Risk of Posttransplant Rejection Episodes
J. Immunol., August 15, 1999; 163(4): 2267 - 2275.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.